Agilon Health Inc (AGL) concluded trading on Wednesday at a closing price of $2.19, with 4.04 million shares of worth about $8.84 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -61.17% during that period and on January 08, 2025 the price saw a gain of about 1.86%. Currently the company’s common shares owned by public are about 411.96M shares, out of which, 303.29M shares are available for trading.
Stock saw a price change of 15.26% in past 5 days and over the past one month there was a price change of 0.92%. Year-to-date (YTD), AGL shares are showing a performance of 15.26% which decreased to -76.14% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.50 but also hit the highest price of $9.30 during that period. The average intraday trading volume for Agilon Health Inc shares is 3.98 million. The stock is currently trading 8.66% above its 20-day simple moving average (SMA20), while that difference is up 3.65% for SMA50 and it goes to -50.02% lower than SMA200.
Agilon Health Inc (NYSE: AGL) currently have 411.96M outstanding shares and institutions hold larger chunk of about 80.58% of that.
The stock has a current market capitalization of $902.32M and its 3Y-monthly beta is at 0.52. It has posted earnings per share of -$0.82 in the same period. It has Quick Ratio of 1.29 while making debt-to-equity ratio of 0.08. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AGL, volatility over the week remained 7.79% while standing at 8.47% over the month.
Stock’s fiscal year EPS is expected to drop by -17.47% while it is estimated to increase by 37.96% in next year.
Coverage by Bernstein stated Agilon Health Inc (AGL) stock as a Mkt perform in their note to investors on December 11, 2024, suggesting a price target of $2.50 for the stock. Stock get a Sell rating from Citigroup on October 30, 2024.
